BIIB vs BMRA · P/E 21, rev $9.89B vs rev $4.5M
Biogen Inc (BIIB) versus Biomerica Inc (BMRA) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Biomerica Inc (BMRA) is a medical devices company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported BMRA revenue for 2026-05-31 was $4.5M. Net income was -$3.8M. Revenue was down 16.2% from 2025-05-31 to 2026-05-31. BMRA currently screens at market cap $8.0M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. BMRA currently screens at market cap $8.0M.
Not investment advice. Open the BIIB and BMRA stock pages for the full models.
Not investment advice.